Sideinnhold
A -
B -
C -
D -
E -
F -
G -
H -
I -
J -
K -
L -
M -
N -
O -
P -
Q -
R -
S -
T -
U -
V -
X -
Y -
Z
(S) = sykehuslegemiddel
| Ibrance (S) | palbociklib | Brystkreft | 2018 |
|---|
| Ibrance (S) | palbociklib | Brystkreft | 2019 |
|---|
| Idelvion (S) | Albutrepenonacog alfa | Hemofili B | 2016 |
|---|
|
Ikervis | ciklosporin | Alvorlig keratitt | 2016 |
|---|
| Ilumetri (S) | Tildrakizumab | Psoriasis | 2019 |
|---|
| Imbruvica (S) | ibrutinib | Kronisk lymfatisk leukemi | 2015 |
|---|
|
Imbruvica (S) | ibrutinib | Mantelcellelymfom | 2016 |
|---|
| Imfinzi (S) | durvalumab | Ikke-småcellet lungekreft | 2019 |
|---|
| Imlygic (S) | Talimogene laherparepvec | Malignt melanom | 2017 |
|---|
| Increlex | mecasermin | Vekstforstyrrelser | 2009 |
|---|
|
Incresync | alogliptin og pioglitazon | Diabetes type 2 | 2014 |
|---|
| formoterol, beklometason | Astma | 2008 |
|---|
| Inuxair | formoterol, beklometason | KOLS | 2014 |
|---|
Intuniv
| guanfacin | ADHD | 2016 |
|---|
| paliperidon | Schizofreni | 2008 |
|---|
| Invokana | kanagliflozin | Diabetes type 2 | 2019 |
|---|
| gefitinib | Lungekreft | 2011 |
|---|
